Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Veraxa partners with Quadira on ADCs for oncology indications

June 16, 2021

Exelixis and Bristol Myers Squibb agree to study XL-092 with immuno-oncology therapies

June 15, 2021

Vor Biopharma and Abound Bio partner to develop multi-targeted CAR-Ts

June 11, 2021

ONK Therapeutics and Trinity College Dublin collaborate in an Enterprise Ireland funded project

June 10, 2021

Shoreline and BeiGene collaborate to develop and commercialize NK-based cell therapies

June 10, 2021

Sorrento Therapeutics and Karolinska Institutet collaborate on iPSC-derived DAR-NK cells

June 7, 2021

Monopar and the National University of Singapore collaborate on development of MNPR-202

June 4, 2021

Corbus licenses integrin-targeting MAbs, CRB-601 and CRB-602

June 4, 2021

Centivax enters strategic partnership with NMRC for phase I development of Centi-B9

June 3, 2021

Immutep and Merck KGaA collaborate on phase I/II study of eftilagimod alpha plus bintrafusp alfa

June 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...